Since the discovery that the endocannabinoid system is involved in emotional memory processing, researchers have begun to examine whether cannabidiol, or CBD, could be an effective therapeutic treatment option for those suffering from PTSD.
A study by Colorado State University sought to determine the pharmacokinetics of cannabidiol (CBD) in dogs.
A study performed by the Department of Clinical Sciences at Colorado State University sought to determine the pharmacokinetics of cannabidiol (CBD) in dogs. Pharmacokinetics examines the bodily absorption, distribution, metabolism and excretion of drugs.
The study performed involved the participation of 30 healthy dogs. Each dog was treated with one of three CBD treatments: oral CBD oil beads, oral CBD oil or CBD skin cream. The dosages were 75mg or 150mg every 12 hours for 6 weeks, with the CBD treatments being dose-proportional. Cannabidiol levels in the dogs’ blood were measured over the course of the 6-week study. The experiment demonstrated that that oral dosages of CBD oil had the best pharmacokinetic profile, as this delivery method demonstrated the highest concentrations of cannabidiol retention in the dogs’ system.
To learn more about the Colorado State University canine study referenced above, please see the link here.
Nectar CBD offers CBD-rich hemp oil pet drops, Nectar 300 Pet Drops and Nectar 600 Pet Drops, which are hemp extract formulated in organic MCT coconut oil. Nectar CBD provides organic CBD oil for sale in Colorado and offers an entire line of CBD products for pets, including pet treats.
CBD could help stop the spread of cancer cells in the lungs and support lung function in general.
CBD was able to prevent further tissue damage and allow the tissue to regenerate and heal faster.
The study confirmed that CBD does in fact seem to possess anti-anxiety properties, which are triggered by CBD’s effect on the limbic and paralimbic brain areas.
In April 2017, European researchers published a study in the Journal of Neuropharmacology that demonstrated the neuroprotective effect of CBD in a rat model of AIS.
Cannabidiol has demonstrated, in studies, to have antiepileptic properties and has had widespread success as a treatment therapy for various types of seizure disorders.
CBD was shown to elevate levels of anandamide, resulting in anti-inflammatory and anti-allergenic properties.
The study confirmed that CBD was successfully able to control RBD symptoms in Parkinson’s patients and was published in the Journal of Clinical Pharmacy and Therapeutics.
Sullivan University College of Pharmacy in Louisville, Kentucky, researched the effects of CBD therapy on ovarian cancer cells.